Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S.

Am J Respir Crit Care Med. 2009 Dec 1;180(11):1122-30. doi: 10.1164/rccm.200902-0242OC. Epub 2009 Aug 27.

2.

Bone marrow stromal cells as immunomodulators. A primer for dermatologists.

Nemeth K, Mezey E.

J Dermatol Sci. 2015 Jan;77(1):11-20. doi: 10.1016/j.jdermsci.2014.10.004. Epub 2014 Oct 31. Review.

3.

The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury.

Rehan VK, Torday JS.

Antioxid Redox Signal. 2014 Nov 1;21(13):1893-904. doi: 10.1089/ars.2013.5793. Epub 2014 Mar 12. Review.

4.

The role of bone marrow-derived stem cells in lung regeneration and repair.

Sage EK, Loebinger MR, Polak J, Janes SM.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2008 Sep 30.

5.

Stem cell-based therapy for neonatal lung disease: it is in the juice.

Fung ME, Thébaud B.

Pediatr Res. 2014 Jan;75(1-1):2-7. doi: 10.1038/pr.2013.176. Epub 2013 Oct 14. Review.

6.

Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia.

Möbius MA, Rüdiger M.

Mol Cell Pediatr. 2016 Dec;3(1):18. doi: 10.1186/s40348-016-0046-6. Epub 2016 May 3. Review.

7.

Potential contribution of type I alveolar epithelial cells to chronic neonatal lung disease.

Rozycki HJ.

Front Pediatr. 2014 May 19;2:45. doi: 10.3389/fped.2014.00045. eCollection 2014. Review.

8.

Bronchopulmonary dysplasia early changes leading to long-term consequences.

Hilgendorff A, O'Reilly MA.

Front Med (Lausanne). 2015 Feb 12;2:2. doi: 10.3389/fmed.2015.00002. eCollection 2015. Review.

Supplemental Content

Support Center